首页> 外国专利> RECOMBINANT PLASMID PFM-IFN-17 PROVIDING EXPRESSION OF INTERFERON ALPHA-2B OF HUMAN, RECOMBINANT PLASMID PFM-AP, PROVIDING EXPRESSION OF ENZYME METHIONINE-AMINOPEPTIDASE E COLI, BIPLASMID STRAIN ESCHERICHIA COLI FM-IFN-AP (PFM-IFN-17, PFM-AP) - PRODUCER (MET-) OF RECOMBINANT INTERFERON ALPHA -2B OF HUMAN

RECOMBINANT PLASMID PFM-IFN-17 PROVIDING EXPRESSION OF INTERFERON ALPHA-2B OF HUMAN, RECOMBINANT PLASMID PFM-AP, PROVIDING EXPRESSION OF ENZYME METHIONINE-AMINOPEPTIDASE E COLI, BIPLASMID STRAIN ESCHERICHIA COLI FM-IFN-AP (PFM-IFN-17, PFM-AP) - PRODUCER (MET-) OF RECOMBINANT INTERFERON ALPHA -2B OF HUMAN

机译:重组质粒PFM-IFN-17可表达人类干扰素ALPHA-2B,重组质粒PFM-AP可表达酶甲硫氨酸-氨基肽酶E COLI,双歧杆菌应变大肠埃希氏菌COLI FM-IFN-AP(PFM-IFN-17P -AP)-人类重组干扰素α-2B的生产者(MET-)

摘要

FIELD: medicine, pharmaceutics.;SUBSTANCE: invention refers to the biotechnologies. The invention represents the recombinant strain of bacteria E. coli FM-IFN, which is produced by means of the successive transformation of the strain cells E. coli BL21 by recombinant plasmid DNA pFM-AP and pFM-IFN-17, recombinant plasmid DNA pFM-AP with the size of 4,582 b.p., which encodes the inducible synthesis of the enzyme methionine-aminopeptidase E.coli under the control of a lactose promoter and contains the gene cm, which determines the resistances to chloramphenicol, as a genetic marker, recombinant plasmid DNA pFM-IFN-17 with the size of 3,215 b.p., which encodes the synthesis of the interferon alpha-2b of a human under the control the lactose and tryptophanic promotor and terminator of the transcription rrnBT1T2 and contains the synthetic gene km, which determines the resistances to kanamycin, as a genetic marker.;EFFECT: production of recombinant interferon aplpha-2b of a human free from methionine on the N-end with the high output and following the simplified technology.;4 cl, 8 dwg, 1 tbl, 6 ex
机译:领域:医药,药物;物质:发明是指生物技术。本发明代表了一种细菌大肠杆菌FM-IFN的重组菌株,它是通过重组质粒DNA pFM-AP和pFM-IFN-17,重组质粒DNA pFM对菌株BL.21菌株的连续转化而产生的。 -AP,大小为4,582 bp,编码在乳糖启动子的控制下诱导的蛋氨酸-氨基肽酶大肠杆菌的合成,并包含基因cm,该基因决定了对氯霉素的抗性,作为遗传标记,重组质粒DNA pFM-IFN-17大小为3,215 bp,编码在转录rrnBT1T2的乳糖和色氨酸启动子和终止子控制下人的干扰素α-2b的合成,并包含合成基因km,它决定了效果:对卡那霉素具有抗性,是一种遗传标记。效果:采用简化的技术,以高产量在N端生产了不含甲硫氨酸的人重组干扰素aplpha-2b。 ; 4 cl,8 dwg,1 tbl,6 ex

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号